GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (OTCPK:DSRLF) » Definitions » Days Sales Outstanding

Diasorin SpA (Diasorin SpA) Days Sales Outstanding : 59.95 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Days Sales Outstanding?

Diasorin SpA's average Accounts Receivable for the three months ended in Dec. 2023 was $217 Mil. Diasorin SpA's Revenue for the three months ended in Dec. 2023 was $330 Mil. Hence, Diasorin SpA's Days Sales Outstanding for the three months ended in Dec. 2023 was 59.95.

The historical rank and industry rank for Diasorin SpA's Days Sales Outstanding or its related term are showing as below:

DSRLF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 56.52   Med: 69.5   Max: 93.34
Current: 66.51

During the past 13 years, Diasorin SpA's highest Days Sales Outstanding was 93.34. The lowest was 56.52. And the median was 69.50.

DSRLF's Days Sales Outstanding is ranked better than
54.22% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.24 vs DSRLF: 66.51

Diasorin SpA's Days Sales Outstanding increased from Dec. 2022 (57.51) to Dec. 2023 (59.95).

Diasorin SpA Days Sales Outstanding Historical Data

The historical data trend for Diasorin SpA's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Days Sales Outstanding Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.92 59.37 58.39 60.62 65.53

Diasorin SpA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.51 68.60 - - 59.95

Competitive Comparison of Diasorin SpA's Days Sales Outstanding

For the Diagnostics & Research subindustry, Diasorin SpA's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diasorin SpA's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Days Sales Outstanding falls into.


Diasorin SpA Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Diasorin SpA's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (233.088 + 216.532) / 2 ) / 1252.137*365
=224.81 / 1252.137*365
=65.53

Diasorin SpA's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0 + 216.532) / 1 ) / 329.564*365 / 4
=216.532 / 329.564*365 / 4
=59.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA  (OTCPK:DSRLF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Diasorin SpA Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA (Diasorin SpA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (OTCPK:DSRLF) » Definitions » Days Sales Outstanding
Comparable Companies
HKSE:08070 HKSE:01379 HKSE:01273 HKSE:01591 HKSE:00380 HKSE:01629 HKSE:00544 HKSE:01758 HKSE:00379 HKSE:01720 TSE:2309 TMO DHR IQV IDXX XSWX:LONN A MTD ICLR ILMN
Traded in Other Exchanges
DIA:Italy 0GZX:UK 34D:Germany
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Website
https://www.diasoringroup.com
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.